Today: Johnson & Johnson (JNJ) Rating Reiterate by Bank of America Corp.

Today: Johnson & Johnson (JNJ) Rating Reiterate by Bank of America Corp.

Johnson & Johnson (NYSE:JNJ)‘s stock had its “hold” rating reaffirmed by research analysts at Bank of America Corp. in a research report issued to clients and investors on Monday. They presently have a $126.00 price target on the stock. Bank of America Corp.’s price objective indicates a potential upside of 10.40% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Leerink Swann reissued a “buy” rating on shares of Johnson & Johnson in a report on Sunday, September 11th. Zacks Investment Research raised Johnson & Johnson from a “hold” rating to a “buy” rating and set a $133.00 target price for the company in a research report on Tuesday, September 13th. Vetr raised Johnson & Johnson from a “hold” rating to a “buy” rating and set a $124.21 target price for the company in a research report on Monday, August 22nd. Deutsche Bank AG reaffirmed a “buy” rating and set a $142.00 target price on shares of Johnson & Johnson in a research report on Friday, August 19th. Finally, Argus reaffirmed a “buy” rating and set a $145.00 target price on shares of Johnson & Johnson in a research report on Friday, October 21st. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $121.02.

Johnson & Johnson (NYSE:JNJ) opened at 114.13 on Monday. The stock’s 50 day moving average price is $116.14 and its 200 day moving average price is $118.35. Johnson & Johnson has a 52-week low of $94.28 and a 52-week high of $126.07. The firm has a market capitalization of $310.49 billion, a PE ratio of 20.03 and a beta of 0.75.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, October 18th. The company reported $1.68 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.66 by $0.02. Johnson & Johnson had a return on equity of 25.30% and a net margin of 22.03%. The company had revenue of $17.80 billion for the quarter, compared to the consensus estimate of $17.71 billion. During the same quarter last year, the business posted $1.49 EPS. Johnson & Johnson’s revenue for the quarter was up 4.2% on a year-over-year basis. On average, analysts predict that Johnson & Johnson will post $6.72 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 6th. Stockholders of record on Tuesday, November 22nd will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.80%. The ex-dividend date is Friday, November 18th. This is an increase from Johnson & Johnson’s previous quarterly dividend of $0.29. Johnson & Johnson’s payout ratio is presently 56.64%.

In other Johnson & Johnson news, Director Charles Prince bought 875 shares of the business’s stock in a transaction dated Friday, October 21st. The shares were purchased at an average price of $114.11 per share, for a total transaction of $99,846.25. Following the purchase, the director now directly owns 26,520 shares of the company’s stock, valued at $3,026,197.20. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.11% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the company. NN Investment Partners Holdings N.V. acquired a new position in shares of Johnson & Johnson during the first quarter worth $92,331,000. Adell Harriman & Carpenter Inc. boosted its stake in Johnson & Johnson by 5.4% in the first quarter. Adell Harriman & Carpenter Inc. now owns 83,918 shares of the company’s stock worth $9,080,000 after buying an additional 4,292 shares during the period. Canandaigua National Bank & Trust Co. boosted its stake in Johnson & Johnson by 0.3% in the first quarter. Canandaigua National Bank & Trust Co. now owns 97,516 shares of the company’s stock worth $10,551,000 after buying an additional 291 shares during the period. Royal Bank of Scotland Group PLC boosted its stake in Johnson & Johnson by 1.7% in the first quarter. Royal Bank of Scotland Group PLC now owns 10,950 shares of the company’s stock worth $1,184,000 after buying an additional 182 shares during the period. Finally, USS Investment Management Ltd boosted its stake in Johnson & Johnson by 38.9% in the first quarter. USS Investment Management Ltd now owns 211,814 shares of the company’s stock worth $22,913,000 after buying an additional 59,314 shares during the period. Hedge funds and other institutional investors own 64.13% of the company’s stock.

About Johnson & Johnson

Related posts

Leave a Comment